Table 3.
Variable | p27 | P value | |
---|---|---|---|
High expressors | Low expressors | ||
Age (years) | |||
≤55 | 14 (54%) | 12 (44%) | NS |
>55 | 12 (46%) | 15 (56%) | |
Race | |||
Caucasian | 23 (89%) | 24 (89%) | NS |
Other | 3 (12%) | 3 (11%) | |
Tumor stage | |||
IIC | 4 (15%) | 3 (11%) | NS |
III | 22 (85%) | 24 (89%) | |
Residual disease | |||
Microscopic | 10 (42%) | 6 (38%) | 0.02 |
<2 cm | 9 (38%) | 5 (19%) | |
>2 cm | 5 (21%) | 15 (58%) | |
Performance status | |||
0 | 10 (39%) | 4 (15%) | 0.02 |
1 | 16 (62%) | 20 (74%) | |
2 | 0 | 3 (11%) | |
Differentiation | |||
Well/moderate | 11 (42%) | 8 (30%) | NS |
Poor | 15 (58%) | 19 (70%) | |
p53 expression | |||
Negative | 11 (44%) | 9 (33%) | NS |
Positive | 14 (56%) | 18 (67%) |
NS, not significant.